Integra LifeSciences Holdings Corporation
IART
$14.05
-$0.14-0.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3,803.18% | -670.89% | -2.01% | -154.86% | -396.41% |
| Total Depreciation and Amortization | 27.01% | 21.66% | 44.23% | -28.79% | -3.73% |
| Total Amortization of Deferred Charges | 29.45% | -0.93% | -2.30% | -5.79% | 2.53% |
| Total Other Non-Cash Items | 2,174.42% | -98.88% | 22.20% | -28.52% | 203.22% |
| Change in Net Operating Assets | -2,022.39% | -5.58% | -218.77% | 109.96% | 106.26% |
| Cash from Operations | -77.92% | -171.45% | -13.63% | -16.01% | 42.87% |
| Capital Expenditure | 32.18% | -87.00% | -20.64% | -126.69% | -91.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 85.69% | 81.82% | 164.75% | 257.74% | -- |
| Cash from Investing | 93.28% | 33.44% | 92.58% | -35.07% | -1,972.28% |
| Total Debt Issued | -78.06% | -85.32% | 94.51% | -83.45% | 1,076.00% |
| Total Debt Repaid | 82.45% | -0.95% | -61.71% | 26.86% | -442.18% |
| Issuance of Common Stock | -- | -85.04% | -100.00% | -100.00% | -100.00% |
| Repurchase of Common Stock | 99.11% | 31.58% | -730.25% | 99.86% | -48,054.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -48.50% | -- | 100.00% | -- | -- |
| Cash from Financing | 77.45% | -90.14% | -3.77% | 59.90% | -776.72% |
| Foreign Exchange rate Adjustments | 1,226.93% | 191.26% | -201.04% | 258.95% | -428.17% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.37% | -102.30% | 1,069.21% | 99.78% | -20,739.45% |